| Original language | English |
|---|---|
| Pages (from-to) | 417-418 |
| Number of pages | 2 |
| Journal | Alimentary Pharmacology and Therapeutics |
| Volume | 59 |
| Issue number | 3 |
| Early online date | 10 Jan 2024 |
| DOIs | |
| Publication status | Published - Feb 2024 |
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
- Pharmacology (medical)
Documents and Links
- Author accepted manuscript
This is the peer reviewed version of the following article: Philip Vutien, Nicole J. Kim, Andrew M. Moon, Kay M. Johnson, Kristin Berry, Pamela K. Green, George N. Ioannou, Editorial: How does the risk of hepatocellular carcinoma change over time in patients with a hepatitis C cure?, Alimentary Pharmacology & Therapeutics, 59, 3, (419-420), (2024)., which has been published in final form at doi.org/10.1111/apt.17818 . This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified.